Literature DB >> 18622468

Seroprevalence and risk factors for hepatitis B virus infection among general population in Northern India.

Rachna Behal1, Renu Jain, Krishan K Behal, Ajay Bhagoliwal, Nakshatra Aggarwal, T N Dhole.   

Abstract

BACKGROUND: Infection with hepatitis-B virus has been a significant cause of morbidity claiming more than a million lives every year. Epidemiological data reveals that there are 360 million carriers of hepatitis-B virus throughout the globe and 78% of the world populations' hail from Asia. Though several studies from Indian sub-continent have provided an estimate of the prevalence of this viral infection, there exist only few studies, which reflect the status in the general population. AIM: The present study was designed to investigate the prevalence of hepatitis-B infection in North Indian general population.
METHODS: The study population comprised of 20,000 healthy blood donors who were screened for hepatitis-B surface antigen (HBsAg) status using third generation ELISA kit. Seroprevalence rate of seropositive donors was calculated and stratified by age, sex and blood groups. Statistical analysis was performed using tests of proportions, chi-square and confidence interval.
RESULTS: The study showed that out of 20,000 donors, 450 (2.25%) were HBsAg positive (95% confidence interval (CI), 2.0445-2.4554). Higher prevalence of HbsAg was found among males (440/19235) than females (10/765). The age specific prevalence rose from 1.78% (108/6058) in donors aged 19-25 years to a maximum of 3.03% (96/3161) in donors aged 35-45 years and decreased in older age groups. The peaks were detected in male donors aged 35-45 years and in females aged 25-35 years. Rh-negative blood group donors (21/873) and Rh-positive group donors (429/19127) had almost equivalent prevalence rates of HBsAg. HBsAg was more prevalent in blood group B donors (174/7426) and less prevalent in AB blood group donors (38/2032).
CONCLUSION: It was found that variables including gender and age were significantly associated with HBsAg positivity. HBsAg positivity in our population was statistically not associated with ABO blood groups.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622468     DOI: 10.1590/s0004-28032008000200009

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  15 in total

1.  Seroprevalence of hepatitis B in healthy blood donors attending tertiary care hospital (SKIMS Soura, Srinagar): a prospective study of 1 year.

Authors:  Mohd Younus Shah; Faisal Younis Shah; Faizan Younis Shah; Muzaffer Naik
Journal:  Indian J Gastroenterol       Date:  2013-07

Review 2.  Risk factors for hepatocellular carcinoma in India.

Authors:  Premashis Kar
Journal:  J Clin Exp Hepatol       Date:  2014-04-13

3.  Seroprevalence of Common Viral Diseases: A Hospital Based Study from Amritsar, India.

Authors:  Kanwardeep Singh; Shailpreet K Sidhu; Pushpa Devi; Manpreet Kaur; Maninder Kaur; Nachhatarjit Singh
Journal:  J Clin Diagn Res       Date:  2016-12-01

4.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

5.  Association of ABO and Rh Blood Groups to Blood-Borne Infections among Blood Donors in Tehran-Iran.

Authors:  Fatemeh Mohammadali; Aliakbar Pourfathollah
Journal:  Iran J Public Health       Date:  2014-07       Impact factor: 1.429

6.  The Prevalence of Transfusion Transmitted Infections in ABO Blood Groups and Rh Type System.

Authors:  Jitendra Singh Nigam; Savitri Singh; Viplesh Kaur; Sumit Giri; Ravi Prakash Kaushal
Journal:  Hematol Rep       Date:  2014-12-04

7.  Prevalence and influencing factors of hepatitis B among a rural residential population in Zhejiang Province, China: a cross-sectional study.

Authors:  Shigui Yang; Cheng Ding; Yuanxia Cui; Jie Wu; Chengbo Yu; Ping Chen; Kaijin Xu; Min Deng; Yiping Li; Juanjuan Liu; Pei Yin; Wen Ren; Yan Qiu; Qing Cao; Yuqing Zhou; Jun Yao; Bing Ruan; Jingjing Ren; Lanjuan Li
Journal:  BMJ Open       Date:  2017-04-03       Impact factor: 2.692

8.  ABO blood groups and hepatitis B virus infection: a systematic review and meta-analysis.

Authors:  Wenzhan Jing; Siyu Zhao; Jue Liu; Min Liu
Journal:  BMJ Open       Date:  2020-02-02       Impact factor: 2.692

9.  Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal.

Authors:  Hans-Tilmann Kinkel; Dibesh Karmacharya; Jivan Shakya; Sulochana Manandhar; Santosh Panthi; Prajwola Karmacharya; Deepika Sitaula; Reenu Thapaliya; Prawachan K C; Apurva Rai; Sameer Dixit
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

10.  Trends in epidemiology of Hepatitis B and C Infections in Ilam Province: National Notifiable Diseases Surveillance System data.

Authors:  Salman Khazaei; Manoochehr Karami; Erfan Ayubi; Abolfazl Mohammadbeigi; Azim Hasanbeigi; Kamyar Mansori; Mohammad Reza Mir-Shekar
Journal:  Caspian J Intern Med       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.